INSTINCT BIO TECHNICAL CO HO
BIOTNASDAQ🏆 #4879 by market capUS Equity
$0.34▼ $0.03 (−9.68%)
LiveTrack BIOT
Get earnings, price moves & breaking news on Telegram
24h▼ 9.7%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$10M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
36
Weak
No chart data available for BIOT.
Trading Snapshot
- Day Range
- $0.34 – $0.35
- 52-Week Range
- $2.00 – $19.00
- Volume
- $3.62B
- Avg Volume
- $3.66B
- Shares Outstanding
- 28.8M
- Next Earnings
- Nov 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $700,761
- Last Q Revenue
- $160,617
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- $-0.18
- Dividend Yield
- —
Why Investors Own BIOT
- ✓High-growth profile — revenue up -9.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 26% gross margin and 26% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
INSTINCT BIO TECHNICAL CO HO
BIOTFinancial Trends
Revenue (TTM)The total money the company brought in from sales, before subtracting any costs.
$700,761▼ −11.8% YoY
Gross Margin (TTM)Of every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
25.8%▲ +2.8% YoY
Operating Income (TTM)Profit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$152,766▼ −11.8% YoY
Free Cash Flow (TTM)Cash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$184,300▼ −11.8% YoY
StockOtter · stockotter.spaceAbout INSTINCT BIO TECHNICAL CO HO
An integrated regenerative medicine and longevity company focused on the research, manufacturing, and commercialization of regenerative health technologies, stem cell-derived products, wellness solutions, and advanced skincare.
🦦
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
💧Dilution★★★★★
Overall Score
Weak
36/100
Analyst Price Target
ⓘAverage Target
$0.35
▲ +2.1% Upside
High Target$0.39
Low Target$0.29
Based on 28 analysts
Latest News & Updates
🚀
MarketWatch·2h ago
INSTINCT BIO TECHNICAL CO HO tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Barron’s·5h ago
Analysts lift BIOT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
MarketWatch·1d ago
INSTINCT BIO TECHNICAL CO HO announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.